Aging exacerbates extrapyramidal motor signs in the era of highly active antiretroviral therapy
- PMID: 18989814
- PMCID: PMC2765397
- DOI: 10.1080/13550280802216494
Aging exacerbates extrapyramidal motor signs in the era of highly active antiretroviral therapy
Abstract
The phenotype of human immunodeficiency virus (HIV)-associated neurocognitive disorders (HAND) in the developed world has changed with the broad institution of highly active antiretroviral therapy (HAART) and with aging of the HIV+ population. Extrapyramidal motor signs were a prominent feature of HAND as defined in the early stages of the epidemic but has not been reevaluated in the era of HAART. Moreover, the contribution of aging to extrapyramidal motor signs in the context of HIV remains undefined. We examined these questions among the 229 HIV+ participants in the Hawaii Aging with HIV Cohort compared to age-, gender-, and ethnicity-matched HIV-negative controls. Extrapyramidal motor signs were quantified using the motor exam of the Unified Parkinson's Disease Rating Scale (UPDRSmotor) and compared to concurrent neuropsychological and clinical cognitive diagnostic categorization. The mean UPDRSmotor score increased with older age (1.68 versus 3.35; P<.001) and with HIV status (1.18 versus 3.56; P<.001). Age group (P=.024), HIV status (P<.001), and the interaction between age and HIV (P=.026) were significantly associated with UPDRSmotor score. Among HIV+ patients, the mean UPDRSmotor score increased with worsening cognitive diagnostic category (P<.001) where it was 2.06 (2.31) in normal cognition (n=110), 3.21 (3.48) in minor cognitive motor disorder (MCMD) (n=84), and 5.72 (5.01) in HIV-associated dementia (HAD) (n=37). We conclude that extrapyramidal motor signs are increased in HIV in the era of HAART and that the impact of HIV on extrapyramidal motor signs is exacerbated by aging. These results highlight the importance of a careful neurological examination in the evaluation of HIV patients.
Figures
Similar articles
-
Motor function and human immunodeficiency virus-associated cognitive impairment in a highly active antiretroviral therapy-era cohort.Arch Neurol. 2008 Aug;65(8):1096-101. doi: 10.1001/archneur.65.8.1096. Arch Neurol. 2008. PMID: 18695060 Free PMC article.
-
Extrapyramidal motor signs in older adults with HIV disease: frequency, 1-year course, and associations with activities of daily living and quality of life.J Neurovirol. 2019 Apr;25(2):162-173. doi: 10.1007/s13365-018-0699-0. Epub 2018 Dec 10. J Neurovirol. 2019. PMID: 30535869
-
Insulin resistance is associated with cognition among HIV-1-infected patients: the Hawaii Aging With HIV cohort.J Acquir Immune Defic Syndr. 2006 Dec 1;43(4):405-10. doi: 10.1097/01.qai.0000243119.67529.f5. J Acquir Immune Defic Syndr. 2006. PMID: 17099311
-
Emerging issues in the neuropsychology of HIV infection.Curr HIV/AIDS Rep. 2008 Nov;5(4):204-11. doi: 10.1007/s11904-008-0029-x. Curr HIV/AIDS Rep. 2008. PMID: 18838060 Free PMC article. Review.
-
[Dementia complex due to HIV disease and aging].Psychol Neuropsychiatr Vieil. 2007 Sep;5(3):193-207. Psychol Neuropsychiatr Vieil. 2007. PMID: 17872328 Review. French.
Cited by
-
Update on HIV dementia and HIV-associated neurocognitive disorders.Curr Neurol Neurosci Rep. 2014 Aug;14(8):468. doi: 10.1007/s11910-014-0468-2. Curr Neurol Neurosci Rep. 2014. PMID: 24938216 Review.
-
Motor-related brain abnormalities in HIV-infected patients: a multimodal MRI study.Neuroradiology. 2017 Nov;59(11):1133-1142. doi: 10.1007/s00234-017-1912-1. Epub 2017 Sep 9. Neuroradiology. 2017. PMID: 28889255
-
Impairments of Motor Function While Multitasking in HIV.Front Hum Neurosci. 2017 Apr 28;11:212. doi: 10.3389/fnhum.2017.00212. eCollection 2017. Front Hum Neurosci. 2017. PMID: 28503143 Free PMC article.
-
Characterization of simian immunodeficiency virus (SIV) that induces SIV encephalitis in rhesus macaques with high frequency: role of TRIM5 and major histocompatibility complex genotypes and early entry to the brain.J Virol. 2014 Nov;88(22):13201-11. doi: 10.1128/JVI.01996-14. Epub 2014 Sep 3. J Virol. 2014. PMID: 25187546 Free PMC article.
-
Cognitive impairment in patients with AIDS - prevalence and severity.HIV AIDS (Auckl). 2015 Jan 29;7:35-47. doi: 10.2147/HIV.S39665. eCollection 2015. HIV AIDS (Auckl). 2015. PMID: 25678819 Free PMC article. Review.
References
-
- Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type 1 (HIV-1) infection. Report of a Working Group of the American Academy of Neurology AIDS Task Force. Neurology. 41:778–85. - PubMed
-
- Ances BM, Roc AC, Wang J, Korczykowski M, Okawa J, Stern J, Kim J, Wolf R, Lawler K, Kolson DL, Detre JA. Caudate blood flow and volume are reduced in HIV+ neurocognitively impaired patients. Neurology. 2006;66:862–6. - PubMed
-
- Becker JT, Lopez OL, Dew MA, Aizenstein HJ. Prevalence of cognitive disorders differs as a function of age in HIV virus infection. Aids. 2004;18(Suppl 1):S11–8. - PubMed
-
- Brew BJ. Evidence for a change in AIDS dementia complex in the era of highly active antiretroviral therapy and the possibility of new forms of AIDS dementia complex. Aids. 2004;18(Suppl 1):S75–8. - PubMed
-
- Cherner M, Ellis RJ, Lazzaretto D, Young C, Mindt MR, Atkinson JH, Grant I, Heaton RK. Effects of HIV-1 infection and aging on neurobehavioral functioning: preliminary findings. Aids. 2004;18(Suppl 1):S27–34. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical